Evidence map›Paper›PMID 28371879›Full record

ArticleRheumatology (Oxford, England)2018

Evaluating the design and reporting of pragmatic trials in osteoarthritis research.

Shabana Amanda Ali, Marita Kloseck, Karen Lee, Kathleen Ellen Walsh, Joy C MacDermid, Deborah Fitzsimmons

Abstract read
In one paragraph

Article in Rheumatology (Oxford, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Can genetics guide exercise prescriptions in osteoarthritis?Frontiers in rehabilitation sciences · 2022
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Shabana Amanda AliFaculty of Health Sciences.
Marita KloseckFaculty of Health Sciences.
Karen LeeFaculty of Health Sciences.
Kathleen Ellen WalshFaculty of Science, University of Western Ontario.
Joy C MacDermidFaculty of Health Sciences.
Deborah FitzsimmonsFaculty of Health Sciences.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Among the challenges in health research is translating interventions from controlled experimental settings to clinical and community settings where chronic disease is managed daily. Pragmatic trials offer a method for testing interventions in real-world settings but are seldom used in OA research. The aim of this study was to evaluate the literature on pragmatic trials in OA research up to August 2016 in order to identify strengths and weaknesses in the design and reporting of these trials. Methods: We used established guidelines to assess the degree to which 61 OA studies complied with pragmatic trial design and reporting. We assessed design according to the pragmatic-explanatory continuum indicator summary and reporting according to the pragmatic trials extension of the CONsolidated Standards of Reporting Trials guidelines. Results: None of the pragmatic trials met all 11 criteria evaluated and most of the trials met between 5 and 8 of the criteria. Criteria most often unmet pertained to practitioner expertise (by requiring specialists) and criteria most often met pertained to primary outcome analysis (by using intention-to-treat analysis). Conclusion: Our results suggest a lack of highly pragmatic trials in OA research. We identify this as a point of opportunity to improve research translation, since optimizing the design and reporting of pragmatic trials can facilitate implementation of evidence-based interventions for OA care.

Indexed as

Guidelines as TopicHumansIntention to Treat AnalysisOsteoarthritisPragmatic Clinical Trials as TopicResearch DesignResearch ReportTranslational Research, BiomedicalCONSORTimplementationosteoarthritispragmatic trialsPRECIS

Identifiers

PMID28371879
PMCPMC5850497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.